Quantcast

Latest cardiac arrhythmias Stories

2010-01-21 05:30:00

MINNEAPOLIS, Jan. 21 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced its participation in the 46th Annual Meeting of the Society of Thoracic Surgeons (STS) and related company-sponsored events. The meeting is scheduled from January 25-27, 2010, in Fort Lauderdale, Florida and serves as one of the year's key gatherings of cardiovascular surgeons from around the world. (Logo:...

2009-11-11 12:19:00

ROCHESTER, N.Y., Nov. 11 /PRNewswire-USNewswire/ -- The University of Rochester Medical Center has announced the creation of a new center that will assist researchers studying the electrical activity of the heart with the goal of improving drug safety, understanding cardiac arrhythmias, and developing new electrocardiograph technologies. The Center for Quantitative Electrocardiology and Cardiac Safety -- funded by a $2.3 million grant from the National Institutes of Health -- brings...

2009-11-02 15:01:00

MINNEAPOLIS, Nov. 2 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today reported financial results for its third quarter ended October 3, 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO) Third Quarter 2009 Results Revenue for the quarter was $18.8 million, or 17.3% higher than the third quarter of 2008. Revenue from the Company's heart valve therapy products,...

2009-10-13 05:30:00

MINNEAPOLIS, Oct. 13 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the receipt of CE Mark for the ATS CryoMaze® 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias. The first use of the 10-S probe in Europe was performed by Professor Friedrich W. Mohr at the Klinik fur Herzchirurgie (Clinic for Heart Surgery) in Leipzig, Germany....

2009-09-20 13:36:25

2 genes represent potential drug targets for both heart and endocrine disease Genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -- a healthy heartbeat -- have now also been found to play a key role in thyroid hormone (TH) biosynthesis, according to Weill Cornell Medical College researchers. The authors' findings, published online this week by the peer-reviewed journal Nature Medicine, suggest that mutations of either of two gene products...

2009-08-24 13:52:33

Cholesterol can affect the flow of the electrical currents that generate the heart beat, causing cardiac arrhythmias, researchers in Canada and France said. Scientists had long known cholesterol plays an important role in regulating the heart's electrical system, but they didn't know how. University of British Columbia researchers David Fedida and Jodene Eldstrom along with researchers in Paris found that too much cholesterol can affect the electrical currents, perhaps causing the heart to...

2009-08-03 15:01:00

MINNEAPOLIS, Aug. 3 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today reported financial results for its second quarter ended July 4, 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO) Second Quarter 2009 Results Revenue for the quarter was $19.8 million, or 17.0% higher than the second quarter of 2008. Revenue from the Company's heart valve therapy products,...

2009-07-20 05:30:00

MINNEAPOLIS, July 20 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first commercial use of the new ATS CryoMaze(TM) 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias. The cryoablation procedure was performed by Niv Ad, MD, Chief of Cardiac Surgery at the Inova Heart & Vascular Institute in Falls Church, Virginia, a premier heart center in the...

2009-06-03 05:30:00

MINNEAPOLIS, June 3 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced participation in the upcoming International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Meeting in San Francisco on June 3-6, 2009. The ISMICS meeting is a significant gathering of cardiovascular surgeons from around the world whose interests include the latest developments in less invasive...

2009-05-04 15:01:00

- First quarter 2009 vs. first quarter 2008: * Revenue increases 24% to $18.4 million * Heart valve therapy revenue rises 24.0% * CryoMaze cryoablation revenue grows 27.4% * Record gross profit of 66.7% vs. 60.3% * Year-over-year operating loss improves 85% MINNEAPOLIS, May 4 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today reported financial results for the first quarter ended April...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'